These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dissociation of somatostatin and parvalbumin interneurons circuit dysfunctions underlying hippocampal theta and gamma oscillations impaired by amyloid β oligomers in vivo. Chung H; Park K; Jang HJ; Kohl MM; Kwag J Brain Struct Funct; 2020 Apr; 225(3):935-954. PubMed ID: 32107637 [TBL] [Abstract][Full Text] [Related]
24. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms]. Šaponjić J Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729 [TBL] [Abstract][Full Text] [Related]
25. Slow Wave Sleep Is a Promising Intervention Target for Alzheimer's Disease. Lee YF; Gerashchenko D; Timofeev I; Bacskai BJ; Kastanenka KV Front Neurosci; 2020; 14():705. PubMed ID: 32714142 [TBL] [Abstract][Full Text] [Related]
27. Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response. He Y; Zheng MM; Ma Y; Han XJ; Ma XQ; Qu CQ; Du YF Biochem Biophys Res Commun; 2012 Dec; 429(3-4):125-30. PubMed ID: 23146634 [TBL] [Abstract][Full Text] [Related]
28. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Viola KL; Klein WL Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547 [TBL] [Abstract][Full Text] [Related]
29. Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer's disease. Marcatti M; Fracassi A; Montalbano M; Natarajan C; Krishnan B; Kayed R; Taglialatela G Cell Mol Life Sci; 2022 Apr; 79(4):222. PubMed ID: 35377002 [TBL] [Abstract][Full Text] [Related]
30. Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease. Duncan MJ; Guerriero LE; Kohler K; Beechem LE; Gillis BD; Salisbury F; Wessel C; Wang J; Sunderam S; Bachstetter AD; O'Hara BF; Murphy MP Neuroscience; 2022 Jan; 481():111-122. PubMed ID: 34856352 [TBL] [Abstract][Full Text] [Related]
31. Identification of intraneuronal amyloid beta oligomers in locus coeruleus neurons of Alzheimer's patients and their potential impact on inhibitory neurotransmitter receptors and neuronal excitability. Kelly L; Seifi M; Ma R; Mitchell SJ; Rudolph U; Viola KL; Klein WL; Lambert JJ; Swinny JD Neuropathol Appl Neurobiol; 2021 Jun; 47(4):488-505. PubMed ID: 33119191 [TBL] [Abstract][Full Text] [Related]
32. Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways. Morroni F; Sita G; Tarozzi A; Rimondini R; Hrelia P Behav Brain Res; 2016 Nov; 314():106-15. PubMed ID: 27498145 [TBL] [Abstract][Full Text] [Related]
33. High-frequency oscillations (250-500 Hz) in animal models of Alzheimer's disease and two animal models of epilepsy. Lisgaras CP; Scharfman HE Epilepsia; 2023 Jan; 64(1):231-246. PubMed ID: 36346209 [TBL] [Abstract][Full Text] [Related]
34. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer's Disease. Cieślik M; Czapski GA; Wójtowicz S; Wieczorek I; Wencel PL; Strosznajder RP; Jaber V; Lukiw WJ; Strosznajder JB Mol Neurobiol; 2020 Mar; 57(3):1374-1388. PubMed ID: 31734880 [TBL] [Abstract][Full Text] [Related]
35. Two novel mouse models of slow-wave-sleep enhancement in aging and Alzheimer's disease. Ogbeide-Latario OE; Ferrari LL; Gompf HS; Anaclet C Sleep Adv; 2022; 3(1):zpac022. PubMed ID: 37193408 [TBL] [Abstract][Full Text] [Related]
36. Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3. Fekete C; Vastagh C; Dénes Á; Hrabovszky E; Nyiri G; Kalló I; Liposits Z; Sárvári M Neuroscience; 2019 May; 405():35-46. PubMed ID: 29522854 [TBL] [Abstract][Full Text] [Related]
37. The visual scoring of sleep and arousal in infants and children. Grigg-Damberger M; Gozal D; Marcus CL; Quan SF; Rosen CL; Chervin RD; Wise M; Picchietti DL; Sheldon SH; Iber C J Clin Sleep Med; 2007 Mar; 3(2):201-40. PubMed ID: 17557427 [TBL] [Abstract][Full Text] [Related]
38. Alterations of sleep oscillations in Alzheimer's disease: A potential role for GABAergic neurons in the cortex, hippocampus, and thalamus. Katsuki F; Gerashchenko D; Brown RE Brain Res Bull; 2022 Sep; 187():181-198. PubMed ID: 35850189 [TBL] [Abstract][Full Text] [Related]
39. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease. Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864 [TBL] [Abstract][Full Text] [Related]
40. The soluble extracellular fragment of neuroligin-1 targets Aβ oligomers to the postsynaptic region of excitatory synapses. Dinamarca MC; Di Luca M; Godoy JA; Inestrosa NC Biochem Biophys Res Commun; 2015 Oct; 466(1):66-71. PubMed ID: 26325471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]